Pharmaceuticals news +
AstraZeneca enters China with Plendil
02 March 2016 | London
AstraZeneca has entered into a licensing agreement with China Medical System (CMS) Holdings for the commercialisation rights in China to its calcium channel blocker, Plendil (felodipine)... readmore

Doctors Without Borders urges lower vaccine prices
26 February 2016 | Addas Abada, Ethiopia
Vaccine prices are skyrocketing in Africa, according to Doctors Without Borders, but the situation is not being adequately addressed by politicians... readmore

PTAB institutes IPR against Pozen
25 February 2016 | Washington DC
The US Patent Trial and Appeal Board (PTAB) has granted the Coalition for Affordable Drugs’s petition to review the patent covering pharmaceutical company Pozen’s ulcer treatment... readmore

Seven pharma join Parkinson's consortium
24 February 2016 | London
Seven pharmaceutical companies have joined an initiative that is aiming to speed up the development of effective therapies for Parkinson’s... readmore

AstraZeneca slams Innopharma for Falsodex generic
23 February 2016 | New Jersey
AstraZeneca has sued Innopharma to block its attempt to produce a generic version of breast cancer treatment Falsodex (fulvestrant)... readmore

FTC and AbbVie row over pay-for-delay deals
23 February 2016 | Pennsylvania
AbbVie and its partner Besins Healthcare have urged a Pennsylvania court to accept that it has provided the US Federal Trade Commission (FTC) with all necessary documentation in a row over pay-for-delay deals... readmore

Sandoz wants Supreme Court to review first BPCIA decision
19 February 2016 | Washington DC
Sandoz has asked the US Supreme Court to review aspects of the Court of Appeals for the Federal Circuit’s ruling concerning the 180-day waiting period for biosimilar makers... readmore

1 2 3 4 >> LAST

FaceBook LinkedIn RSS feed Blog Instagram Twitter
Specialist features +
Country profiles ++
Interviews +++
Matters of import
20 January 2016
Alireza Behrooz of Merchant & Gould and Nick Phillips of Edwin Coe discuss parallel importation of pharmaceuticals in the US and Europe readmore

Raising the bar
16 December 2015
Amendments to the US Civil Rules of Procedure could dissuade some non-practicing entities from targeting technology-rich sectors readmore

Making connections
02 December 2015
Changes are coming to the UK Patent Box to meet new international standards readmore

More features
06 January 2016
Australia’s IP system has come under the spotlight as the government considers possible reforms. Naomi Pearce and Nigel Lokan of K&L Gates speak to Tammy Facey readmore

11 September 2015
Mohan Dewan and Disha Dewan of R K Dewan & Co report on the ban on any changes to patent specifications or claims at the time of national phase entry via the Patent Cooperation Treaty in India readmore

11 September 2015
The fear that natural products would be privatised soon, or one cannot study a product of nature and benefit from it if another legally possesses it, is always in the minds of all stakeholders. D. Calab Gabriel and Maria Gabriel of Lex IP Care discuss the patenting of natural bio-materials in India readmore

More country profiles
Terry Mahn
Fish & Richardson
03 February 2016
Terry Mahn of Fish & Richardson discusses the issues still to be resolved in the Food and Drug Administration’s proposed naming system for biosimilars readmore

Rogelio Nicandro
Romulo LLP
04 November 2015
Rogelio Nicandro of Romulo LLP offers some handy tips for stopping trademark infringement in the Philippines readmore

Grant Shoebridge
Shelston IP
04 November 2015
Grant Shoebridge of Shelston IP unpacks the Australian High Court’s Myriad decision readmore

More interviews
IPPro Life Sciences


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization